Literature DB >> 35502615

Epigenetic aberrations of gene expression in a rat model of hepatocellular carcinoma.

Cayla Boycott1, Megan Beetch1, Tony Yang1, Katarzyna Lubecka2, Yuexi Ma1, Jiaxi Zhang1, Lucinda Kurzava Kendall3,4, Melissa Ullmer5, Benjamin S Ramsey6, Sandra Torregrosa-Allen6, Bennett D Elzey6,7, Abigail Cox7, Nadia Atallah Lanman6,7, Alisa Hui8, Nathaniel Villanueva8, Aline de Conti9, Tao Huan8, Igor Pogribny9, Barbara Stefanska1.   

Abstract

Hepatocellular carcinoma (HCC) is mostly triggered by environmental and life-style factors and may involve epigenetic aberrations. However, a comprehensive documentation of the link between the dysregulated epigenome, transcriptome, and liver carcinogenesis is lacking. In the present study, Fischer-344 rats were fed a choline-deficient (CDAA, cancer group) or choline-sufficient (CSAA, healthy group) L-amino acid-defined diet. At the end of 52 weeks, transcriptomic alterations in livers of rats with HCC tumours and healthy livers were investigated by RNA sequencing. DNA methylation and gene expression were assessed by pyrosequencing and quantitative reverse-transcription PCR (qRT-PCR), respectively. We discovered 1,848 genes that were significantly differentially expressed in livers of rats with HCC tumours (CDAA) as compared with healthy livers (CSAA). Upregulated genes in the CDAA group were associated with cancer-related functions, whereas macronutrient metabolic processes were enriched by downregulated genes. Changes of highest magnitude were detected in numerous upregulated genes that govern key oncogenic signalling pathways, including Notch, Wnt, Hedgehog, and extracellular matrix degradation. We further detected perturbations in DNA methylating and demethylating enzymes, which was reflected in decreased global DNA methylation and increased global DNA hydroxymethylation. Four selected upregulated candidates, Mmp12, Jag1, Wnt4, and Smo, demonstrated promoter hypomethylation with the most profound decrease in Mmp12. MMP12 was also strongly overexpressed and hypomethylated in human HCC HepG2 cells as compared with primary hepatocytes, which coincided with binding of Ten-eleven translocation 1 (TET1). Our findings provide comprehensive evidence for gene expression changes and dysregulated epigenome in HCC pathogenesis, potentially revealing novel targets for HCC prevention/treatment.

Entities:  

Keywords:  DNA methylation; Transcriptomics; liver cancer; oncogenes

Mesh:

Substances:

Year:  2022        PMID: 35502615      PMCID: PMC9586690          DOI: 10.1080/15592294.2022.2069386

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.861


  85 in total

1.  Genome-wide study of hypomethylated and induced genes in patients with liver cancer unravels novel anticancer targets.

Authors:  Barbara Stefanska; David Cheishvili; Matthew Suderman; Ani Arakelian; Jian Huang; Michael Hallett; Ze-Guang Han; Mamun Al-Mahtab; Sheikh Mohammad Fazle Akbar; Wasif Ali Khan; Rubhana Raqib; Imrana Tanvir; Haseeb Ahmed Khan; Shafaat A Rabbani; Moshe Szyf
Journal:  Clin Cancer Res       Date:  2014-04-24       Impact factor: 12.531

2.  Definition of the landscape of promoter DNA hypomethylation in liver cancer.

Authors:  Barbara Stefanska; Jian Huang; Bishnu Bhattacharyya; Matthew Suderman; Michael Hallett; Ze-Guang Han; Moshe Szyf
Journal:  Cancer Res       Date:  2011-07-11       Impact factor: 12.701

Review 3.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

4.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

5.  A functional transsulfuration pathway in the brain links to glutathione homeostasis.

Authors:  Victor Vitvitsky; Mark Thomas; Anuja Ghorpade; Howard E Gendelman; Ruma Banerjee
Journal:  J Biol Chem       Date:  2006-09-27       Impact factor: 5.157

6.  The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets.

Authors:  W F Zapisek; G M Cronin; B D Lyn-Cook; L A Poirier
Journal:  Carcinogenesis       Date:  1992-10       Impact factor: 4.944

7.  Protective effect of grape seed and skin extract against high-fat diet-induced liver steatosis and zinc depletion in rat.

Authors:  Kamel Charradi; Salem Elkahoui; Ines Karkouch; Ferid Limam; Fethy Ben Hassine; Michèle Veronique El May; Ezzedine Aouani
Journal:  Dig Dis Sci       Date:  2014-04-06       Impact factor: 3.199

8.  Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes.

Authors:  Barbara Stefanska; Aurelie Bouzelmat; Jian Huang; Matthew Suderman; Michael Hallett; Ze-Guang Han; Mamun Al-Mahtab; Sheikh Mohammad Fazle Akbar; Wasif Ali Khan; Rubhana Raqib; Moshe Szyf
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

Review 9.  Resveratrol and cancer: focus on in vivo evidence.

Authors:  Lindsay G Carter; John A D'Orazio; Kevin J Pearson
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.